Head-to-Head Comparison between Xpert MTB/RIF Assay and Real-Time Polymerase Chain Reaction Assay Using Bronchial Washing Specimens for Tuberculosis Diagnosis
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- ESCIKCIScopus
- 저널 순위
- Scopus Q2KCI Q1
- 저널
- Tuberculosis and Respiratory Diseases85(1) · pp.89 · 2022
- 피인용
- Scopus 9KCI 3
- FWCI (Scopus)
- 0.76
- ISSN
- 1738-3536
저자
- 손은정제1저자Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 장진옥Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 김태화Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 장진호Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 정재헌Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 설희윤Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 여혜주Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 윤성훈Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 이승은Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 조우현Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 김윤성Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
- 전두수교신저자Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
초록
Copyright © 2022 The Korean Academy of Tuberculosis and Respiratory Diseases.Background: With the introduction of Xpert MTB/RIF assay (Xpert), its incorporation into tuberculosis (TB) diagnostic algorithm has become an important issue. The aim of this study was to evaluate the performance of the Xpert assay in comparison with a commercial polymerase chain reaction (PCR) assay. Methods: Medical records of patients having results of both Xpert and AdvanSure TB/NTM real-time PCR (AdvanSure) assays using the same bronchial washing specimens were retrospectively reviewed. Results: Of the 1,297 patients included in this study, 205 (15.8%) were diagnosed with pulmonary TB. Using mycobacterial culture as the reference method, sensitivity of the Xpert assay using smear-positive specimens was 97.5%, which was comparable to that of the AdvanSure assay (96.3%, p=0.193). However, the sensitivity of the Xpert assay using smear-negative specimens was 70.6%, which was significantly higher than that of the AdvanSure assay (52.9%, p=0.018). Usng phenotypic drug susceptibility testing as the reference method, sensitivity and specificity for detecting rifampicin resistance were 100% and 99.1%, respectively. Moreover, a median turnaround time of the Xpert assay was 1 day, which was significantly shorter than 3 days of the AdvanSure assay (p<0.001). Conclusion: In comparison with the AdvanSure assay, the Xpert assay had a higher sensitivity using smear-negative specimens, a shorter turnaround time, and could reliably predict rifampin resistance. Therefore, the Xpert assay might be preferentially recommended over TB-PCR in Korean TB diagnostic algorithm.
키워드
Molecular Diagnostic TechniquesPolymerase Chain ReactionTuberculosis
식별자
- Scopus EID
- 2-s2.0-85123534827
- KCI
- ART002798166



로그인
연구물 목록으로